Madrigal Pharmaceuticals(CH:YDO1)
CH:YDO1
Madrigal Pharmaceuticals Revenue
Madrigal Pharmaceuticals (YDO1) Revenue
0 Followers
Madrigal Pharmaceuticals Revenue
Madrigal Pharmaceuticals had a revenue of 431.27M in the quarter ending Sep 30, 2026, with 18.40%. This bring the company's revenue in the last twelve months to 1.43B, Increased 11.22%. In the fiscal year ending Dec 31, 2025, Madrigal Pharmaceuticals had annual revenue of 958.40M with 432.05% growth.
- Revenue (ttm)
- 1.43B
- Revenue Growth
- ―
- P/S Ratio
- 8.73
- Revenue/Employee
- CHF 1,047,435
- Employees
- 915
- Market Cap
- CHF 8.36B
Revenue Chart
Madrigal Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 958.40M | 778.27M | 432.05% |
| Dec 31, 2024 | 180.13M | 180.13M | ― |
| Dec 31, 2023 | 0.00 | 0.00 | ― |
| Dec 31, 2022 | 0.00 | 0.00 | ― |
| Dec 31, 2021 | 0.00 | 0.00 | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.